NCT07163000View on ClinicalTrials.gov

Earlier Diagnosis of Peripheral Neuropathy Using A Simple sCreening Tool (ACT)

Active, not recruitingOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

May 11, 2025

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions

Peripheral NeuropathyPainful NeuropathyDiabetes (DM)

Trial Locations (1)

24144

Weill Cornell Medicine-Qatar, Doha

Sponsors

Collaborators (1)

Hamad Medical Corporation

All Listed Sponsors

collaborator

Procter and Gamble

INDUSTRY

collaborator

Hamad Medical Corporation

INDUSTRY

lead

Weill Cornell Medical College in Qatar

OTHER